Johnson & Johnson Announces Updated Financials and 2023 Guidance Following Completion of the Kenvue Separation
Company expects increased 2023 Reported Sales Growth of 7.0% - 8.0%, Operational Sales Growth of 7.5% - 8.5%, and Adjusted Operational Sales Growth of 6.2% - 7.2%; Figures exclude the COVID-19...
Joaquin Duato Kenvue Inc Johnson Consumer Health Consumer Health Consumer Health Company Company Consumer Health
Source: marketscreener.com